Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier

Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier

This study synthesized a reduced graphene oxide-silica-based (rGO/SiO2) nanocomposite for quercetin delivery as an anticancer model drug delivery. The synthesized rGO/SiO2 nanocomposite was investigated by several characterization methods such as Fourier-transform infrared (FT-IR) spectroscopy, X-ra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biointerface Research in Applied Chemistry 2023-08, Vol.13 (4), p.383
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 383
container_title Biointerface Research in Applied Chemistry
container_volume 13
description This study synthesized a reduced graphene oxide-silica-based (rGO/SiO2) nanocomposite for quercetin delivery as an anticancer model drug delivery. The synthesized rGO/SiO2 nanocomposite was investigated by several characterization methods such as Fourier-transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) analysis, and Transmission electron microscopy (TEM), and Energy-dispersive X-ray spectroscopy (EDX). The experiments result show that the rGO/SiO2 nanocomposite has been synthesized successfully and has an average particle size of 50-120 nm.
doi_str_mv 10.33263/BRIAC134.383
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_33263_BRIAC134_383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_33263_BRIAC134_383</sourcerecordid><originalsourceid>FETCH-LOGICAL-c232t-bab9ac7c7602258f61c42ab217cb3bd95bcbfbed5dab07f3f91b93090f02e03f3</originalsourceid><addsrcrecordid>eNpNkMFLwzAYxYMoOOaO3vMPdEvyrU1zrJ1ug-Fg03NJ0i8a6dqSbOL-e4tT8F3e4_F4hx8h95xNAUQGs4fduig5zKeQwxUZCZapJM1BXv_Lt2QS4wcblEqRAx-R_Q7rk8WaLoPu37FFuv3yNc72vvFW02fddrY79F30R6Q60qI9Dn1rMdBFOL3RBTb-E8P5stQheAx35MbpJuLk18fk9enxpVwlm-1yXRabxAoQx8Roo7SVVmZMiDR3GbdzoY3g0howtUqNNc5gndbaMOnAKW4UMMUcE8jAwZgkl18buhgDuqoP_qDDueKs-oFS_UGpBijwDYHGVeA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier</title><source>EZB-FREE-00999 freely available EZB journals</source><description>This study synthesized a reduced graphene oxide-silica-based (rGO/SiO2) nanocomposite for quercetin delivery as an anticancer model drug delivery. The synthesized rGO/SiO2 nanocomposite was investigated by several characterization methods such as Fourier-transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) analysis, and Transmission electron microscopy (TEM), and Energy-dispersive X-ray spectroscopy (EDX). The experiments result show that the rGO/SiO2 nanocomposite has been synthesized successfully and has an average particle size of 50-120 nm.</description><identifier>ISSN: 2069-5837</identifier><identifier>EISSN: 2069-5837</identifier><identifier>DOI: 10.33263/BRIAC134.383</identifier><language>eng</language><ispartof>Biointerface Research in Applied Chemistry, 2023-08, Vol.13 (4), p.383</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><title>Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier</title><title>Biointerface Research in Applied Chemistry</title><description>This study synthesized a reduced graphene oxide-silica-based (rGO/SiO2) nanocomposite for quercetin delivery as an anticancer model drug delivery. The synthesized rGO/SiO2 nanocomposite was investigated by several characterization methods such as Fourier-transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) analysis, and Transmission electron microscopy (TEM), and Energy-dispersive X-ray spectroscopy (EDX). The experiments result show that the rGO/SiO2 nanocomposite has been synthesized successfully and has an average particle size of 50-120 nm.</description><issn>2069-5837</issn><issn>2069-5837</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkMFLwzAYxYMoOOaO3vMPdEvyrU1zrJ1ug-Fg03NJ0i8a6dqSbOL-e4tT8F3e4_F4hx8h95xNAUQGs4fduig5zKeQwxUZCZapJM1BXv_Lt2QS4wcblEqRAx-R_Q7rk8WaLoPu37FFuv3yNc72vvFW02fddrY79F30R6Q60qI9Dn1rMdBFOL3RBTb-E8P5stQheAx35MbpJuLk18fk9enxpVwlm-1yXRabxAoQx8Roo7SVVmZMiDR3GbdzoY3g0howtUqNNc5gndbaMOnAKW4UMMUcE8jAwZgkl18buhgDuqoP_qDDueKs-oFS_UGpBijwDYHGVeA</recordid><startdate>20230815</startdate><enddate>20230815</enddate><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20230815</creationdate><title>Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c232t-bab9ac7c7602258f61c42ab217cb3bd95bcbfbed5dab07f3f91b93090f02e03f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><collection>CrossRef</collection><jtitle>Biointerface Research in Applied Chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier</atitle><jtitle>Biointerface Research in Applied Chemistry</jtitle><date>2023-08-15</date><risdate>2023</risdate><volume>13</volume><issue>4</issue><spage>383</spage><pages>383-</pages><issn>2069-5837</issn><eissn>2069-5837</eissn><abstract>This study synthesized a reduced graphene oxide-silica-based (rGO/SiO2) nanocomposite for quercetin delivery as an anticancer model drug delivery. The synthesized rGO/SiO2 nanocomposite was investigated by several characterization methods such as Fourier-transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) analysis, and Transmission electron microscopy (TEM), and Energy-dispersive X-ray spectroscopy (EDX). The experiments result show that the rGO/SiO2 nanocomposite has been synthesized successfully and has an average particle size of 50-120 nm.</abstract><doi>10.33263/BRIAC134.383</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2069-5837
ispartof Biointerface Research in Applied Chemistry, 2023-08, Vol.13 (4), p.383
issn 2069-5837
2069-5837
language eng
recordid cdi_crossref_primary_10_33263_BRIAC134_383
source EZB-FREE-00999 freely available EZB journals
title Reduced Graphene Oxide/Silica Nanocomposite as Anticancer Drug Delivery Nanocarrier
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A43%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Graphene%20Oxide/Silica%20Nanocomposite%20as%20Anticancer%20Drug%20Delivery%20Nanocarrier&rft.jtitle=Biointerface%20Research%20in%20Applied%20Chemistry&rft.date=2023-08-15&rft.volume=13&rft.issue=4&rft.spage=383&rft.pages=383-&rft.issn=2069-5837&rft.eissn=2069-5837&rft_id=info:doi/10.33263/BRIAC134.383&rft_dat=%3Ccrossref%3E10_33263_BRIAC134_383%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true